CDSCO Panel Approves Roche's Protocol Amendment Proposal For Anti-cancer Drug Atezolizumab, Lenvatinib, and Sorafenib Study Dr. Divya Colin14 April 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Targeted Drug Therapy to help survival in Liver Cancer Niveditha Subramani29 Jan 2024 7:38 PM ISTAs researchers learn more about the changes in cells that cause cancer, they have been able to develop newer drugs that specifically target these...
Roche Gets CDSCO Nod To Study Anticancer FDC Drug Dr. Divya Colin25 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Roche has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central...
Dose Escalation of Lenvatinib effective for Differentiated Thyroid Carcinoma, study finds Dr.Niharika Harsha B6 July 2022 7:30 PM ISTDose escalation of Lenvatinib has successfully been used to treat Differentiated Thyroid carcinoma (DTC) based on a study that was published in the...
AstraZeneca gets CDSCO nod to conduct Phase III CT of antineoplastic FDCs drug Dr. Divya Colin24 May 2022 10:45 AM ISTNew Delhi: Suggesting to increase the number of subjects in clinical trial to 34, from the proposed 24 subjects in India, the Subject Expert Committee...
Merck, Eisai get Japanese nod for cancer cocktail drug Keytruda, Lenvima Ruchika Sharma30 Dec 2021 12:22 PM ISTKenilworth: Merck, known as MSD outside the United States and Canada, and Eisai have announced that the Japanese Ministry of Health, Labour and...
BDR Pharma launches generic version of Lenvatinib for cancer treatment in India Ruchika Sharma22 Oct 2020 10:00 AM ISTLenvatinib is a molecule used to provide breakthrough therapy treatment for cancer patients.
